Nightingale Initiative for Global Health (NIGH) USA, Inc. – Trademark Portfolio
Entity Type: 99
Nightingale Initiative for Global Health (NIGH) USA, Inc. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include NIGH. The owner is based in Arlington, VA.
901 S. Randolph Street
Arlington, VA 22204
Showing of trademarks Trademarks
Trademark Classifications
Nightingale Initiative for Global Health (NIGH) USA, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Nightingale Initiative for Global Health (NIGH) USA, Inc. have?
Nightingale Initiative for Global Health (NIGH) USA, Inc. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Nightingale Initiative for Global Health (NIGH) USA, Inc. file in?
Nightingale Initiative for Global Health (NIGH) USA, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 41 (Education & Entertainment). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Nightingale Initiative for Global Health (NIGH) USA, Inc.'s most well-known trademarks?
Nightingale Initiative for Global Health (NIGH) USA, Inc.'s registered trademark portfolio includes well-known marks such as NIGH. These are among 1 currently registered trademark in the portfolio.
What is Nightingale Initiative for Global Health (NIGH) USA, Inc.'s trademark registration success rate?
Nightingale Initiative for Global Health (NIGH) USA, Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.